Drug profile · INN
pentoxifylline
PENTOXIFYLLINE
pentoxifylline (PENTOXIFYLLINE) is a 3',5'-cyclic phosphodiesterase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — pentoxifylline
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
pentoxifylline (PENTOXIFYLLINE) is a 3',5'-cyclic phosphodiesterase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
3',5'-cyclic phosphodiesterase inhibitor
Primary target: 3',5'-cyclic phosphodiesterase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pentoxifylline?
pentoxifylline (PENTOXIFYLLINE) is a 3',5'-cyclic phosphodiesterase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pentoxifylline?
PENTOXIFYLLINE is a marketed brand name for pentoxifylline. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pentoxifylline?
pentoxifylline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.